RepliCel Life Sciences Inc (TSXV:RP)
RepliCel is a regenerative medicine company developing autologous cell therapies that address diseases caused by a deficit of healthy cells required for normal healing and function.
Happy Life Tech of Beijing, an AI-based clinical/post-marketing CRO, teamed up with Pharmaceutical Product Development, a global clinical-stage CRO, to provide drug developers in China with clinical trial management and post-launch testing. The two companies expect their alliance will help to bring foreign drugs to China and, conversely, bring China drug products to global markets. The collaboration intends to provide clients with China services, including clinical study protocol design, site selection, patient recruitment and real-world evidence.
Source: China Biotoday
